Product Information
ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.7091 per EA under NDC 50742024690. Its NADAC has been published 205 times since Sep 21, 2022.
FDA first approved this application on Apr 6, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET
Isosorbide dinitrate and hydralazine hydrochlorideStrength
37.5; 20 mg/1; mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742024690
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDRALAZINE HYDROCHLORIDE; ISOSORBIDE DINITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA215586FDA Approved
4/6/2022
TE Code
AB
On Market Since
4/12/2022
Pharmacological Classes
Price Statistics
The NADAC for ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET has been published 205 times since Sep 21, 2022, and over the history we have for it it has declined 48.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7091 per EA |
|---|---|
| All-time high | $2.2084 (Aug 16, 2023) |
| All-time low | $0.6998 (Nov 19, 2025) |
| 52-week high | $0.7961 |
| 52-week low | $0.6998 |
| Median price | $1.0083 |
| Average price | $1.1769 |
| Largest weekly change | -22.9% (Aug 23, 2023) |
| Weeks tracked | 205 |
| Tracking since | Sep 21, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $0.7091 per EA (NDC 50742024690), effective Aug 19, 2026.
How has the price of ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET has declined 48.5%. It has been tracked across 205 weekly CMS publications since Sep 21, 2022.
What are the highest and lowest recorded NADAC prices for ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET?
Since Sep 21, 2022, the NADAC for ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET has ranged from a low of $0.6998 (Nov 19, 2025) to a high of $2.2084 (Aug 16, 2023), with a median of $1.0083 per EA.
Are there cheaper alternatives to ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET?
ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET (NDC 50742024690) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.